Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-650032 with peginterferon alfa-2a and ribavirin in treatment-naive chronic hepatitis C
2009-013652-69Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of asunaprevir in hepatitis C virus infection (2 arms), sponsored by Bristol Myers Squibb. Primary endpoints: Safety, Antiviral activity and 2 more. Started Nov 2009; status: completed.
02
Drugs
asunaprevir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on 2009-013652-69.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013652-69.